AI drug discovery
Also, Syntekabio has launched its cloud service platform for AI drug discovery.
Also, scientists from the University of South Australia have developed tiny fibre sensors for remote patient monitoring.
Also, Standigm has partnered with Merck Korea for AI drug discovery research.
They aim to bring down the period and costs for new drug development.
The multiyear agreement will focus on speeding clinical trials and drug development in oncology and nonalcoholic steatohepatitis.
Also, Genesis MedTech has acquired Chinese valve replacement device maker JC Medical.
This news comes just months after Exscientia went public.
The partners aim to accelerate the discovery of novel anti-tubercular drug candidates.
The company said the latest round brings its total raise to $47 million.
This collaboration will work with an unnamed pharma company in Japan to know how its drugs behave compared to rival products.